Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health

A large proportion of the world’s disease burden is attributable to mental illnesses. Although effective interventions are available, many patients still have limited access to evidence-based treatments. Aside from access, treatment gaps, including inappropriate medication selection and monitoring,...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuhec, Matej, Hahn, M., Taskova, I., Bayraktar, I., Fitzgerald, I., Molitschnig, L., Tatarević, A., Lindner, N., Agnoletto, L., da Costa, F. Alves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600282/
https://www.ncbi.nlm.nih.gov/pubmed/37755642
http://dx.doi.org/10.1007/s11096-023-01643-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600282/
https://www.ncbi.nlm.nih.gov/pubmed/37755642
http://dx.doi.org/10.1007/s11096-023-01643-4

Ejemplares similares